Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-25-000003

Chairperson & CEO sold 8,000 shares at an average $398.55 ($3,188,374)

  • Chairperson & CEO acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-09-09 Exercise or conversion : show line 1 in the form 10b5-1 +8,000 $120.26 $962,080 8,130 D
2025-09-09 Sale : show line 2 in the form 10b5-1 −6,165 $398.29 $2,455,427 1,965 D
2025-09-09 Sale : show line 3 in the form 10b5-1 −1,835 $399.43 $732,947 130 D
Open-market sales · 8,000 sh · avg $398.55 · $3,188,374

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2025-09-09 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option −8,000 $120.26 2026-03-15 8,000 286,000 D
Loading xslF345X05/primarydocument.xml…